Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Safe and Effective Method for Wheat Oral Immunotherapy Pubmed



Khayatzadeh A1 ; Gharaghozlou M1 ; Ebisawa M2 ; Shoormasti RS3 ; Movahedi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Allergy and Clinical Immunology, Children's Medical Center, Tehran University of Medical Sciences, Iran
  2. 2. Department of Pediatrics, Department of Allergy, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan
  3. 3. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Allergy# Asthma and Immunology Published:2016


Abstract

At present the only available management for food allergy is avoidance; however, abstaining from allergic foods can affect the quality of life. Oral Immunotherapy (OIT) is an efficient method for increasing tolerance towards food allergens. The aim of this study was desensitizing patients above five years of age with wheat allergy and evaluating the safety and efficacy of OIT for children with IgE-mediated wheat allergy. The method of Rush Oral Immunotherapy (ROIT) was performed on 8 anaphylactic wheat allergic patients as well as outpatient method on 5 non-anaphylactic ones. In ROIT, build-up phase was performed during several days, but in outpatient, the amount of ingestion gradually increased to 5.2 g wheat protein within several weeks. After that, maintenance doses were prescribed daily for 3 months. Then, if the oral food challenge (OFC) was negative, the patients were considered to be in desensitized state, which meant they had to continue eating same doses without interruption. In ROIT, build-up phase continued for about 4.6 days with 71 doses and 21 patients showed clinical symptoms (29.6%). On the contrary, outpatient method lasted approximately 72.4 days in which 356 doses were used and only 9 patients showed symptoms (2.5%). In total-regardless of type of build-up phase- 12 patients could complete the maintenance phase with 1080 doses that 28 of them (2.6%) developed mild symptoms. Our OIT study proved to be safe and effective, although it is utterly evident that further investigation on more patients is necessary. © Copyright Autumn 2016, Iran J Allergy Asthma Immunol. All rights reserved.
Related Docs
1. Impact of Ige-Mediated Food Allergy on Parental Quality of Life in Iranian Patients, Iranian Journal of Allergy# Asthma and Immunology (2016)
2. Evaluation of Tolerance in Patients With Type-1 Hypersensitivity Reaction to Wheat After Oral Immunotherapy, Journal of Investigational Allergology and Clinical Immunology (2016)
3. The Efficacy of Oral Immunotherapy in Patients With Cow's Milk Allergy, Iranian Journal of Allergy# Asthma and Immunology (2017)
5. Asthma and Allergy, Clinical Immunology (2022)
Experts (# of related papers)